Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Norbert_Bischofberger
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focus |
oncology
precision medicine |
| gptkbp:foundedYear |
2017
|
| gptkbp:founder |
gptkb:Norbert_Bischofberger
|
| gptkbp:headquartersLocation |
gptkb:Cambridge,_Massachusetts
gptkb:San_Mateo,_California |
| https://www.w3.org/2000/01/rdf-schema#label |
Kronos Bio
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
gptkb:entospletinib
KB-0742 |
| gptkbp:numberOfEmployees |
~100
|
| gptkbp:publiclyTraded |
true
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
KRON
|
| gptkbp:website |
https://www.kronosbio.com/
|
| gptkbp:bfsParent |
gptkb:Fine_Structure_Ventures
|
| gptkbp:bfsLayer |
7
|